|
|
| (11) | Number of the document | C 2435025 |
| (68) | Number of the document | 2435025 |
| (21) | Application number for Supplementary Protection Certificate | PA 2019 014 |
| (22) | Date of filing the application | 2019-06-17 |
| (41) | Date of publication of the application | 2019-07-10 |
| Date of publication of SPC | 2021-02-10 | |
| (24) | Date of coming into effect of SPC | 2030-05-29 |
| (71) |
Pearl Therapeutics, Inc.,
200 Saginaw Drive, Redwood City, CA 94063,
US
|
| (73) |
Pearl Therapeutics, Inc.,
200 Saginaw Drive, Redwood City, CA 94063,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | EU/1/18/1339, 2018-12-18 |
| (94) | 2033-12-20 |
| (95) | Glikopironio bromidas/formoterolis |
| SPC granted |